U1 snRNP-mediated poly(A) site suppression: Beneficial and deleterious for mRNA fate

RNA Biology

Volumn 10, Issue 2, 2013, Pages 180-184

  Langemeier, Jörg ^a   Radtke, Maximilian ^a   Bohne, Jens ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

3' UTR; Genetic disease; Polyadenylation; RNA processing; U1 site

Indexed keywords

MESSENGER RNA PRECURSOR; POLYADENYLIC ACID; PROTEIN TYROSINE KINASE; SMALL NUCLEAR RIBONUCLEOPROTEIN;

3' UNTRANSLATED REGION; ARTICLE; GENETIC DISORDER; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; POLYADENYLATION; RNA SPLICING; SPLICEOSOME;

EID: 84874623273     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.23314     Document Type: Article

References (32)

1. Wahl MC, Will CL, Lührmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009; 136:701-18; PMID:19239890; http://dx.doi. org/10.1016/j.cell.2009.02.009.
2. Burge CB, Tuschl T, Sharp PA. Splicing of precursors to mRNAs by the spliceosomes. In: Cech TR, ed. The RNA world. Cold Spring Habor, NY, 1999:525-60.
3. Yang VW, Lerner MR, Steitz JA, Flint SJ. A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences. Proc Natl Acad Sci USA 1981; 78:1371-5; PMID:6940164; http://dx.doi.org/10.1073/ pnas.78.3.1371.
4. Furth PA, Choe WT, Rex JH, Byrne JC, Baker CC. Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol Cell Biol 1994; 14:5278-89; PMID:8035806.
5. Furth PA, Baker CC. An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. J Virol 1991; 65:5806-12; PMID:1717710.
6. Proudfoot NJ. Ending the message: poly(A) signals then and now. Genes Dev 2011; 25:1770-82; PMID:21896654; http://dx.doi.org/10.1101/gad.17268411.
7. Danckwardt S, Hentze MW, Kulozik AE. 3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J 2008; 27:482-98; PMID:18256699; http://dx.doi. org/10.1038/sj.emboj.7601932.
8. Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev 1997; 11:2755-66; PMID:9353246; http://dx.doi.org/10.1101/gad.11.21. 2755.
9. Danckwardt S, Kaufmann I, Gentzel M, Foerstner KU, Gantzert AS, Gehring NH, et al. Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals. EMBO J 2007; 26:2658-69; PMID:17464285; http://dx.doi.org/10.1038/sj.emboj.7601699.
10. Gunderson SI, Polycarpou-Schwarz M, Mattaj IW. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol Cell 1998; 1:255-64; PMID:9659922; http://dx.doi.org/10.1016/ S1097-2765(00)80026-X.
11. Ashe MP, Pearson LH, Proudfoot NJ. The HIV-1 5' LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site. EMBO J 1997; 16:5752-63; PMID:9312033; http://dx.doi.org/10.1093/emboj/16.18. 5752.
12. Guan F, Caratozzolo RM, Goraczniak R, Ho ES, Gunderson SI. A bipartite U1 site represses U1A expression by synergizing with PIE to inhibit nuclear polyadenylation. RNA 2007; 13:2129-40; PMID:17942741; http://dx.doi.org/10.1261/ rna.756707.
13. Goraczniak R, Behlke MA, Gunderson SI. Gene silencing by synthetic U1 adaptors. Nat Biotechnol 2009; 27:257-63; PMID:19219028; http://dx.doi. org/10.1038/nbt.1525.
14. Kaida D, Berg MG, Younis I, Kasim M, Singh LN, Wan L, et al. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 2010; 468:664-8; PMID:20881964; http://dx.doi. org/10.1038/nature09479.
15. Vorlová S, Rocco G, Lefave CV, Jodelka FM, Hess K, Hastings ML, et al. Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation. Mol Cell 2011; 43:927-39; PMID:21925381; http://dx.doi.org/10.1016/j.molcel.2011.08.009.
16. Langemeier J, Schrom EM, Rabner A, Radtke M, Zychlinski D, Saborowski A, et al. A complex immunodeficiency is based on U1 snRNP-mediated poly(A) site suppression. EMBO J 2012; 31:4035-44; PMID:22968171; http://dx.doi.org/10.1038/ emboj.2012.252.
17. Bohn G, Allroth A, Brandes G, Thiel J, Glocker E, Schäffer AA, et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007; 13:38-45; PMID:17195838; http://dx.doi. org/10.1038/nm1528.
18. Rigo F, Martinson HG. Functional coupling of lastintron splicing and 3'-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage. Mol Cell Biol 2008; 28:849-62; PMID:17967872; http://dx.doi.org/10.1128/MCB.01410-07.
19. Lu S, Cullen BR. Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells. RNA 2003; 9:618-30; PMID:12702820; http://dx.doi.org/10.1261/rna.5260303.
20. Nott A, Meislin SH, Moore MJ. A quantitative analysis of intron effects on mammalian gene expression. RNA 2003; 9:607-17; PMID:12702819; http://dx.doi.org/10.1261/rna.5250403.
21. Goraczniak R, Gunderson SI. The regulatory element in the 3'-untranslated region of human papillomavirus 16 inhibits expression by binding CUGbinding protein 1. J Biol Chem 2008; 283:2286-96; PMID:18042543; http://dx.doi.org/10. 1074/jbc. M708789200.
22. Kolev NG, Steitz JA. Symplekin and multiple other polyadenylation factors participate in 3'-end maturation of histone mRNAs. Genes Dev 2005; 19:2583-92; PMID:16230528; http://dx.doi.org/10.1101/gad.1371105.
23. Friend K, Lovejoy AF, Steitz JA. U2 snRNP binds intronless histone pre-mRNAs to facilitate U7-snRNP-dependent 3' end formation. Mol Cell 2007; 28:240-52; PMID:17964263; http://dx.doi. org/10.1016/j.molcel.2007.09.026.
24. Dominski Z, Marzluff WF. Formation of the 3' end of histone mRNA: getting closer to the end. Gene 2007; 396:373-90; PMID:17531405; http://dx.doi. org/10.1016/j.gene.2007.04.021.
25. Vagner S, Rüegsegger U, Gunderson SI, Keller W, Mattaj IW. Position-dependent inhibition of the cleavage step of pre-mRNA 3'-end processing by U1 snRNP. RNA 2000; 6:178-88; PMID:10688357; http://dx.doi.org/10.1017/ S1355838200991854.
26. Shi Y. Alternative polyadenylation: new insights from global analyses. RNA 2012; 18:2105-17; PMID:23097429; http://dx.doi.org/10.1261/rna.035899.112.
27. Berg MG, Singh LN, Younis I, Liu Q, Pinto AM, Kaida D, et al. U1 snRNP determines mRNA length and regulates isoform expression. Cell 2012; 150:53-64; PMID:22770214; http://dx.doi.org/10.1016/j. cell.2012.05.029.
28. Di Giammartino DC, Nishida K, Manley JL. Mechanisms and consequences of alternative polyadenylation. Mol Cell 2011; 43:853-66; PMID:21925375; http://dx.doi.org/10.1016/j.molcel. 2011.08.017.
29. Jenal M, Elkon R, Loayza-Puch F, van Haaften G, Kühn U, Menzies FM, et al. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 2012; 149:538-53; PMID:22502866; http://dx.doi.org/10.1016/j. cell.2012.03.022.
30. Martin G, Gruber AR, Keller W, Zavolan M. Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length. Cell Rep 2012; 1:753-63; PMID:22813749; http://dx.doi. org/10.1016/j.celrep.2012.05.003.
31. Martinson HG. An active role for splicing in 3'-end formation. Wiley Interdiscip Rev RNA 2011; 2:459-70; PMID:21957037; http://dx.doi.org/10.1002/ wrna.68.
32. Calvo O, Manley JL. Strange bedfellows: polyadenylation factors at the promoter. Genes Dev 2003; 17:1321-7; PMID:12782649; http://dx.doi. org/10.1101/gad.1093603.